2023 Germline EQA scheme registration closes in:

Webinar Series Now Available – EGFR Liquid Biopsy EQA scheme for Lung Cancer Results Review & Laboratory Best Practice

9 months ago

Thank you to all the participants who attended the 2021 EGFR Liquid Biopsy for Lung Cancer EQA Results Review and Laboratory Best Practice webinar.

We are sharing with our members, the recording of the webinar listed below.

The webinar, hosted Dr. Alexander Yarunin, the Associate Director of Molecular Diagnostics, Scientific Affairs, Global Oncology Diagnostics Astrazeneca, discusses EQA and why it is important for precision medicine, by looking at the results from the 2021 liquid biopsy EQA scheme for lung cancer, as well as why there should be an increase of the use of Liquid Biopsy testing for EGFR profiling.

An expert panel consisting of Dr. Simon Patton, Chief Executive, EMQN CIC, Manchester, UK; Prof. Sandi Deans, Director, Genomics Quality Assessment (GenQA), Edinburgh, UK; and Dr Christian Rolfo, Associate Director for Clinical Research, Center for Thoracic Oncology, Tisch Cancer Institute, New York, USA present the above topics.

Next: Sherlock Biosciences to Acquire Sense Biodetection
Translate »